Vertex Pharmaceuticals (VRTX) EV to EBIT (2009 - 2026)

Vertex Pharmaceuticals (VRTX) EV to EBIT (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to EBIT
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 232,854.65
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -41,251.84
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 604.41
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 25.48
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn 10,112.54
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 15.49
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 43.12
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 49.30
9 Revolution Medicines 37.15 Bn 37.15 Bn - -84.03
10 Moderna 28.64 Bn 23.43 Bn -566.00 Mn -6.87

Historic Data

Download Data
DateValue
Jul 17, 2026 24.81
Jul 16, 2026 24.83
Jul 15, 2026 24.35
Jul 14, 2026 24.31
Jul 13, 2026 24.52
Jul 10, 2026 24.80
Jul 9, 2026 25.40
Jul 8, 2026 25.51
Jul 7, 2026 26.80
Jul 6, 2026 27.20
Jul 2, 2026 27.11
Jul 1, 2026 25.48
Jun 30, 2026 25.41
Jun 29, 2026 25.57
Jun 26, 2026 25.12
Jun 25, 2026 24.52
Jun 24, 2026 24.25
Jun 23, 2026 23.88
Jun 22, 2026 23.79
Jun 18, 2026 22.97